Drug Profile
A1110U
Alternative Names: BW 1110U81Latest Information Update: 26 Jul 1994
Price :
$50
*
At a glance
- Originator Burroughs Wellcome
- Class Antivirals; Hydrazones
- Mechanism of Action Ribonucleotide reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections; Varicella zoster virus infections